Following positive domestic pilot study results for its flagship bloodstream infection (BSI) test, Australian company Microbio has appointed US clinical research consultants the Landrich Group to manage clinical evaluation trials across four sites in the USA, India, South America and Australia, with plans to submit the data generated to secure marketing clearance in Europe, India, USA and Australia. Click to read more...